Filter by

EMBL Australia Newsletter – June 2021

Newsletters / 14 November 2021

News this quarter:

  • Lights out for Parkinson’s disease
  • Major Cancer Council grant for Dr Weatheritt
  • Discovery may help boost peptide design
  • Professor David Lynn talks everything COVID vaccines
  • 2021 EMBL Australia PhD Course applications
  • 2021 EMBL Australia Postgraduate Symposium registrations now open
  • 2020 Highlights report now available 

And more:

  • Job opportunities 
  • Student opportunities 
  • Upcoming events
  • Recent publications

Genes in the human genome are made of DNA. Upon gene expression, a segment of DNA is copied into another molecule called RNA. When gene regulation goes wrong, diseases like cancer can occur. Therefore, knowing how enzymes — highly efficient protein nanomachines — work to switch genes on and off enables the development of new drugs and diagnostics. 

EMBL Australia Newsletter - March 2021

Newsletters / 17 March 2021

News this quarter:

  • A tribute to Scientia Professor Katharina Gaus FAHMS
  • Reversing severe muscle wasting in disease, ageing & trauma
  • Hint as to how SARS-CoV-2 might subvert immune defences
  • Enabling the early and accurate diagnosis of Parkinson’s disease
  • More than $4.8m awarded to EMBL Australia researchers in NHMRC Ideas Grants
  • This protein empowers cancer cells – targeting it could kickstart new therapies
  • Professor Ian Smith to chair the EMBL Australia Council 
  • Innovative research takes us one step closer to developing an effective malaria vaccine
  • Did you know you can access EMBL's cutting-edge scientific services?
  • Get to know: Dr Vaishnavi Ananthanarayanan


And more:

  • Job opportunities
  • Upcoming events
  • Recent publications

EMBL Australia - 2020 Highlights

Annual Reports / 14 March 2021

Despite the challenges and disruptions imposed by the global COVID-19 pandemic, the EMBL Australia Partner Laboratory Network continued to produce fantastic science, attract highly competitive research grants and grow in size. Many of our researchers contributed scientifically to the international battle against coronavirus and continued to build up Australia's research infrastructure capabilities across the various PLN host institutions.